ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,459Medicare Part D Prescriptions Filled, Including Refills

Rank: 35 out of 337

$525K Total Retail Price of All Prescriptions

Rank: 63 out of 337

524 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
27% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Rhode Island
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 524 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

6% of this provider’s 524 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 12,492 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$39 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
LISINOPRIL 877 779 1 2
OMEPRAZOLE 516 430 2 4
FUROSEMIDE 482 470 3 8
AMLODIPINE BESYLATE 477 474 4 3
SIMVASTATIN 461 419 5 1
ATORVASTATIN CALCIUM 423 384 6 7
HYDROCHLOROTHIAZIDE 421 415 7 9
LEVOTHYROXINE SODIUM 378 360 8 5
METOPROLOL TARTRATE 361 348 9 6
PRAVASTATIN SODIUM 284 272 10 14
ATENOLOL 254 244 11 10
LOSARTAN POTASSIUM 230 226 12 15
WARFARIN SODIUM 226 209 13 11
TRAZODONE HCL 219 188 14 16
GLIPIZIDE 181 181 15 45
ALENDRONATE SODIUM 175 158 16 19
QUINAPRIL HCL 175 175 16 50
GABAPENTIN 170 166 18 20
DIOVAN 168 168 19 26
ISOSORBIDE MONONITRATE ER 162 162 20 70
GLIPIZIDE ER 146 130 21 69
CITALOPRAM HBR 137 129 22 17
SERTRALINE HCL 133 126 23 18
HYDROCODONE-ACETAMINOPHEN 124 115 S3 24 13
METOPROLOL SUCCINATE 117 113 25 21
MELOXICAM 116 115 26 54
METFORMIN HCL ER 107 81 27 52
TRAMADOL HCL 104 89 28 32
FLUTICASONE PROPIONATE 100 84 29 34
LIPITOR 98 88 30 33
GLIPIZIDE XL 97 83 31 123
JANUVIA 96 84 32 81
ALPRAZOLAM 95 95 33 78
EVISTA 95 95 33 102
DOXAZOSIN MESYLATE 93 93 35 68
VERAPAMIL ER 92 92 36 77
ZETIA 92 80 36 89
KLOR-CON M20 87 82 38 65
TAMSULOSIN HCL 87 87 38 25
AGGRENOX 87 87 38 174
DILTIAZEM 24HR ER 86 80 41 76
SPIRIVA 83 81 42 43
PREDNISONE 82 81 43 40
PROAIR HFA 82 60 43 38
ALLOPURINOL 81 81 45 28
FENOFIBRATE 69 54 46 48
METFORMIN HCL 69 69 46 12
RANITIDINE HCL 68 56 48 30
SYNTHROID 65 65 49 41
FLUOXETINE HCL 64 42 50 57
ENALAPRIL MALEATE 64 64 50 37
NAMENDA 64 64 50 35
CEFUROXIME 63 58 53 167
LOVASTATIN 63 63 53 24
DONEPEZIL HCL 63 63 53 22
CLOPIDOGREL 62 57 56 42
AZITHROMYCIN 61 56 57 51
CIPROFLOXACIN HCL 59 47 58 71
PANTOPRAZOLE SODIUM 58 47 59 36
DIGOXIN 58 58 59 58
MIRTAZAPINE 58 58 59 27
PROPRANOLOL HCL 55 55 62 121
AMITRIPTYLINE HCL 52 52 R 63 75
NEXIUM 51 42 64 56
ZOLPIDEM TARTRATE 51 42 64 23
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.